Possibility of discontinuation of nilotinib in a patient with chronic myelogenous leukemia in the deep molecular response phase
E Wąsik-Szczepanek - Hematology in Clinical Practice, 2020 - journals.viamedica.pl
The advent of tyrosine kinase inhibitors (TKI) into the management of patients with chronić
myelogenous leukemia (CML) has profoundly improved prognosis. In recent years, a numer …
myelogenous leukemia (CML) has profoundly improved prognosis. In recent years, a numer …
[PDF][PDF] Successful maternal and fetal outcome in a patient with chronic myeloid leukemia on chemotherapy
N Jaiswal, H Khullar, G Mediratta… - International Journal of …, 2020 - academia.edu
Chronic myeloid leukemia (CML) is a myeloproliferative-neoplasm accounting for 15% of
adult leukemias. Management of leukemia in pregnancy and effect of anti-neoplastic agents …
adult leukemias. Management of leukemia in pregnancy and effect of anti-neoplastic agents …
[PDF][PDF] VU Research Portal
W Brink - Neuropsychopharmacology, 2009 - research.vu.nl
Pathological gambling (PG) is associated with maladaptive perseverative behavior, but the
underlying mechanism and neural circuitry is not completely clear. Here, the hypothesis was …
underlying mechanism and neural circuitry is not completely clear. Here, the hypothesis was …
挙児希望のある慢性骨髄性白血病患者の治療
近藤健 - 臨床血液, 2022 - jstage.jst.go.jp
抄録 チロシンキナーゼ阻害薬 (TKI) の登場により慢性骨髄性白血病 (CML)
の予後は劇的に改善し, 現在では健常者とほぼ同等の生命予後が期待できる. また近年では …
の予後は劇的に改善し, 現在では健常者とほぼ同等の生命予後が期待できる. また近年では …
[引用][C] Новые принципы терапии больных хроническим миелолейкозом
ЕЮ Челышева - 2021 - elibrary.ru
[引用][C] Протокол лечения хронического миелолейкоза во время беременности
ЕЮ Челышева, АГ Туркина - Алгоритмы диагностики и протоколы …, 2018 - elibrary.ru
[引用][C] НОВЫЕ ПРИНЦИПЫ ТЕРАПИИ БОЛЬНЫХ ХРОНИЧЕСКИМ МИЕЛОЛЕЙКОЗОМ
АГ Туркина, СИ Куцев - Москва, 2021